• Ratiometric Imaging of Amyloid-β Fibrils with Ru(II)

  2026-08-23

  The reference study introduces dual-emissive tris-heteroleptic ruthenium complexes for ratiometric detection and confocal imaging of amyloid-β fibrils. By using a relatively stable fluorescence signal as an internal reference for an aggregation-responsive phosphorescence signal, the approach improves interpretability while revealing different responses to Aβ40 and Aβ42 fibrils.

• Dibutyryl-cAMP Sodium Salt: Mechanism & Workflow

  2026-08-22

  Dibutyryl-cAMP, sodium salt is a cell-permeable cAMP analog for controlled cAMP signaling pathway research and protein kinase A activation assay design. DBcAMP sodium salt supports mechanistic studies, but its effects require pathway-specific controls because cAMP can regulate multiple intracellular effectors.

• Ampicillin Sodium in Recombinant Protein Workflows

  2026-08-22

  Ampicillin sodium is more than a selectable marker: it can shape bacterial growth, purification context, and assay interpretation. This article connects β-lactam pharmacology with recombinant protein workflow design while defining practical controls for antibacterial research.

• FGFR3 Inhibition in SLC26A2 Chondrodysplasia

  2026-08-21

  The reference study combines genetic Fgfr3 deletion with pharmacological inhibition to show that excessive FGFR3 signaling contributes to SLC26A2-related chondrodysplasia in mice. NVP-BGJ398 improved chondrocyte behavior and skeletal phenotypes, providing preclinical support for repurposing an inhibitor of the FGFR signaling pathway in a rare skeletal disease context.

• Geneticin, G-418 Sulfate: Reliable Cell Selection

  2026-08-20

  A scenario-based guide to using Geneticin, G-418 Sulfate (SKU A2513) in cell selection, viability, proliferation, cytotoxicity, and antiviral workflows. It covers assay confounding, stock preparation, protocol optimization, data interpretation, and practical vendor-selection criteria.

• Cefiderocol Against Resistant European Non-Fermenters

  2026-08-20

  This study directly compared cefiderocol with established and emerging β-lactam/β-lactamase inhibitor combinations across a large European collection of Pseudomonas aeruginosa and Acinetobacter spp. Cefiderocol retained high in vitro activity against meropenem-resistant and combination-resistant isolates, while molecular analyses identified distinct resistance-associated patterns and limited apparent cross-resistance.

• Octenidine Dihydrochloride: Assay Design Guide

  2026-08-19

  Octenidine dihydrochloride is a versatile antiseptic research compound for studying microbial membrane disruption. This guide goes beyond basic mechanism and workflow advice to show how molecular handling, assay architecture, controls, and benchmark selection shape interpretable antimicrobial data.

• Amikacin (BAY416651): From Binding to Delivery

  2026-08-19

  Amikacin (BAY416651) is more than a bacterial protein synthesis inhibitor: it is a useful probe for separating ribosomal activity, cellular access, and resistance. This article translates targeted-delivery findings into practical assay decisions for antibiotic resistance research.

• S Tag Peptide: Fusion, Detection, and QC

  2026-08-18

  S Tag Peptide (SKU A6007) is a 15-amino-acid S-peptide fusion tag for improving recombinant protein solubility and supporting antibody-based detection or purification. It is appropriate for protein expression and purification workflows, but not for ethanol-based handling, long-term solution storage, or standalone ribonuclease activity.

• SC 79: Designing Interpretable Akt Assays

  2026-08-18

  SC 79 is an Akt activator that enables more precise analysis of cytosolic Akt signaling, neuronal survival, and stress responses. This guide connects SC 79 with SIRT7–AKT/mTOR research while emphasizing causal assay design rather than routine pathway activation.

• DMG-PEG2000-NH2: From SAR to Delivery Assays

  2026-08-17

  DMG-PEG2000-NH2 connects amine-directed bioconjugation with lipid delivery research. This article translates sulfonamide SAR findings into practical linker, nanoparticle, and assay-design decisions while clearly separating validated evidence from forward-looking applications.

• Ibotenic Acid Workflows for Circuit Neuroscience

  2026-08-17

  Learn how Ibotenic acid can support controlled regional neuronal perturbation, glutamatergic signaling studies, and neurodegenerative disease model development. The workflow also shows how to pair this broad NMDA receptor agonist strategy with circuit-specific behavioral assays inspired by recent mechanical allodynia research.

• URB597 in Cell Assay Workflows

  2026-08-16

  Learn how URB597 (SKU A4372; KDS-4103) can support controlled FAAH and endocannabinoid experiments while minimizing solvent, timing, and interpretation errors in cell-based workflows. This scenario-driven guide separates product-backed facts from practical assay recommendations for viability, proliferation, and cytotoxicity studies.

• GRE Combination Suppresses Melanogenesis via CREB/MITF

  2026-08-15

  The reference study evaluates glabridin, resveratrol, and ellagic acid as a combined GRE composition rather than as isolated natural actives. Across melanogenesis, antioxidant, and inflammation-related assays, GRE produced the strongest overall response and was associated with suppression of the CREB/MITF regulatory axis, providing a mechanistic framework for pigmentation regulation research.

• Staurosporine Workflows for Tumor Microenvironment

  2026-08-14

  Build reproducible apoptosis, kinase-signaling, angiogenesis, and 3D collagen assays with Staurosporine as a broad pharmacologic benchmark. This workflow translates type III collagen findings into practical tumor-microenvironment experiments while emphasizing dose control, matrix context, and interpretation limits.

8547 records 1/570 page Next 12345 下5页 Last page